ReadYourDNA

Candesartan (Atacand)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Candesartan

What it is

Candesartan is an angiotensin II receptor blocker (ARB): it stops angiotensin II from narrowing blood vessels and making the body hold salt. It is used for high blood pressure and heart failure, and sometimes to prevent migraine. It is sold as Atacand and Amias, among other names.

How genes come into it

Candesartan is given as a prodrug that is activated in the gut wall and cleared mostly unchanged by the kidneys and bile, with only a small part broken down by CYP2C9. Studies have looked at the receptor gene AGTR1, at CYP11B2 (aldosterone synthase), and at genes flagged by genome-wide studies (SH2B3, KCNK3 and others) for how much blood pressure fell. The findings come from single or a few studies, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Candesartan. Upload your DNA file to see which of these rows apply to you.

Rated evidence (7 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

CYP11B2 rs1799998: Level 3. Efficacy: Hypertension. 1.

AGTR1 rs5186: Level 3. Efficacy: Heart Failure. 1.

GPR83 rs3758785: Level 3. Efficacy: Essential hypertension. 1.

KCNK3 rs1275988: Level 3. Efficacy: Hypertension. 1.

Response (11 findings)

Studies of how well it worked in people carrying a variant.

AGTR1 rs5186: Genotype AA is associated with increased response to candesartan in people with Heart Failure as compared to genotype AC.

AGTR1 rs5186: Genotype AC is associated with increased response to candesartan in people with Heart Failure as compared to genotype AA.

CYP11B2 rs1799998: Genotype GG is associated with increased response to candesartan in people with Hypertension as compared to genotypes AA + AG.

DOT1L, PLEKHJ1 rs740406: Allele A is associated with decreased response to candesartan in people with Hypertension as compared to allele G.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

ARBs (class) (ARBs)

Avapro (ARBs)

Cozaar (ARBs)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com